Dr. Incavo and colleagues recently revealed results from their study, Clinical Outcome Evaluation of Intraosseous Vancomycin in Total Knee Arthroplasty (TKA).  The study, recently published in Arthroplasty Today, studies patients receiving intraosseous (IO) vancomycin infusions to protect against methicillin-resistant Staphyloccoccus aureus in total joint replacement surgery compared to intravenous (IV) access. The study compared complication rates in IO and IV TKA cases.  Read more.